19.08.2019 • News

Elkem Buys South Korea’s Basel Chemie

Elkem Buys South Korea’s Basel Chemie
Elkem Buys South Korea’s Basel Chemie

Norwegian silicon producer Elkem is buying Basel Chemie, a South Korean producer of specialty silicon gels, for $26.9 million. Elkem said the deal gives it access to leading technology in attractive end-user silicon segments and a solid platform for further development and growth.

Basel Chemie manufactures silicon for use in skin care and cosmetics applications and in water repellents for the construction industry. It has a manufacturing plant near Gunsan and a R&D center and offices in Seoul. The company employs 32 people and had a turnover of $7.7 million in 2018.

“This acquisition strengthens our position in downstream specialized silicones. Basel Chemie complements our market offering and brings additional technologies to our specialty portfolio in Asia where we have strong positions in other segments,” said Elkem’s CEO Helge Aasen.

The acquisition is expected to close by the end of September, subject to regulatory approvals.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.